Blog

Canary Ovary Team is approaching a milestone of completing its first study of fallopian tubes.

November 1, 2023

The Canary Ovary Team’s initiative to tackle High Grade Serous Ovarian Cancer (HGSOC) is approaching a milestone of completing its first study of fallopian tubes from women with and without mutations in the BRCA genes.

HGSOC arises from the fallopian tubes, is the most common and deadly type of ovarian cancer, and women with BRCA mutations are at higher risk. The team has been carefully studying tubes to find whether there are BRCA-associated signals present at the molecular level, even in BRCA mutant tubes that appear “normal” under the microscope.

When complete, this study will be the largest of its kind and will serve as a definitive resource for follow-up studies and for the research community focused on detecting ovarian cancer early.